Alto Neuroscience
ANRO
NYSE
IPO2024
about ANRO
Alto Neuroscience is a biotechnology company focused on developing innovative treatments for neurodegenerative diseases such as Alzheimer's, utilizing precision medicine approaches to target specific genetic risk factors associated with these conditions.
| type | open | high | low |
market cap |
volume |
|---|---|---|---|---|---|
| stock | $4.76 | $8.46 | $4.71 | $186.56M | 61.88M |
| eps |
price to earnings |
price to sales |
operating margin |
profit margin |
yield |
| -$0.56 | n/a | n/a | 0% | 0% | 0% |